Read the new papers published in PLoS Medicine this week, including a Research Article that analyzes the initial outbreak, attempts at containment…

As part of its longstanding efforts towards providing greater accountability, the US Food and Drug Administration (FDA) has just released a set…

Guest blog by Ditte A. Søndergaard1, Simone C. Hald1,3, Jeffrey V. Lazarus2,3 1 Department of Public Health, Copenhagen University, Copenhagen, Denmark 2…

Guest blog by Dr. Tido von Schoen-Angerer, Executive Director, Access to Essential Medicines Campaign, Médecins Sans Frontières/Doctors Without Borders (MSF), Geneva, Switzerland…

Last week I attended a conference on Open Access in Poland. The meeting, hosted by the Polish Academy of Sciences, came at…

Read the new papers published in PLoS Medicine this week, including a Policy Forum that argues there is an urgent need for…

Guest blog by Gavin Yamey, lead, E2Pi (Evidence-to-Policy initiative), Global Health Group, University of California San Francisco. [email protected] The dust has now…

If the figure is licensed under the Creative Commons Attribution License (CCAL), then an author does not need to obtain permission to…

The 3rd International Congress on Physical Activity and Public Health concluded today with the release of The Toronto Charter on Physical Activity…

So I wasn’t the only one who thought it was odd that the Coca Cola Company was the lead corporate sponsor of this…

Read the new papers published in PLoS Medicine this week, including a Research Article that reviewed the published epidemiological literature on SARS…

I’m currently at the International Harm Reduction Association (IHRA) annual conference in Liverpool, UK, learning about the growing problem of injection drug…